BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18778343)

  • 1. Combined radiation and hormonal therapy or dose escalation for men with unfavourable-risk prostate cancer: an evidence-based approach using a synthesis of randomized clinical trials.
    Nanda A; D'Amico AV
    BJU Int; 2008 Nov; 102(10):1366-8. PubMed ID: 18778343
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant treatment to radiation: combined hormone therapy and external radiotherapy for locally advanced prostate cancer.
    Bolla M; Descotes JL; Artignan X; Fourneret P
    BJU Int; 2007 Jul; 100 Suppl 2():44-7. PubMed ID: 17594359
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate cancer update: 2005.
    Ryan CJ; Small EJ
    Curr Opin Oncol; 2006 May; 18(3):284-8. PubMed ID: 16552242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advanced prostatic carcinoma--which hormone therapy when?].
    Studer UE
    Urologe A; 1995 Sep; 34(5):361-6. PubMed ID: 7483151
    [No Abstract]   [Full Text] [Related]  

  • 5. Duration of testosterone suppression and the risk of death from prostate cancer in men treated with radiation and 6 months of hormone therapy.
    Palma D; Pickles T
    Cancer; 2008 May; 112(10):2322-3; author reply 2323. PubMed ID: 18327816
    [No Abstract]   [Full Text] [Related]  

  • 6. Words of wisdom: Re: High-risk prostate cancer treated with pelvic radiotherapy and 36 versus 18 months of androgen blockade: results of a phase III randomized study [abstract 3].
    Bolla M
    Eur Urol; 2013 Sep; 64(3):513. PubMed ID: 23915463
    [No Abstract]   [Full Text] [Related]  

  • 7. Early hormonal therapy in prostate cancer.
    Swanson GP
    N Engl J Med; 2000 Apr; 342(16):1215-6. PubMed ID: 10777375
    [No Abstract]   [Full Text] [Related]  

  • 8. [Complex treatment of prostate cancer patients].
    Sviridova TV; Dunchik VN; Mardynskiĭ IuS; Tsodikova LB
    Urol Nefrol (Mosk); 1984; (2):9-13. PubMed ID: 6719653
    [No Abstract]   [Full Text] [Related]  

  • 9. [Radiotherapy in prostate cancer: data from ASTRO 2008].
    Coquard R
    Prog Urol; 2009 May; 19(5):297-300. PubMed ID: 19393533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapeutics in development for prostate cancer.
    Harzstark AL; Small EJ
    Oncologist; 2009 Apr; 14(4):391-8. PubMed ID: 19342474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic therapy for prostate cancer.
    Berry WR
    N C Med J; 2006; 67(2):154-7. PubMed ID: 16752722
    [No Abstract]   [Full Text] [Related]  

  • 12. Twenty-five year evolution of medical hormonal therapy for prostate cancer.
    Moul JW
    BJU Int; 2009 Jan; 103(2):145-6. PubMed ID: 19278531
    [No Abstract]   [Full Text] [Related]  

  • 13. Advanced prostate cancer treatment guidelines: a United States perspective.
    Amling CL
    BJU Int; 2004 Dec; 94 Suppl 3():7-8. PubMed ID: 15521885
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormonal implications in the development and treatment of prostate cancer.
    Ip C; Hall SJ
    Endocrinol Metab Clin North Am; 2007 Jun; 36(2):421-34. PubMed ID: 17543727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings of the 1st International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer. Boston, Massachusetts, March 29-30, 1996.
    Urology; 1997 Mar; 49(3A Suppl):1-118; quiz 121-3. PubMed ID: 9123726
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current hormone therapy of prostate cancer].
    Perevodchikova NI; Bukharkin BV
    Vopr Onkol; 1996; 42(4):7-11. PubMed ID: 8928465
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interest of the radiotherapy-hormonotherapy association in the treatment of the high-risk prostate cancer].
    Bolla M; Fourneret P; Descotes JL
    Bull Cancer; 2008 Dec; 95(12):1213-8. PubMed ID: 19091656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key targets of hormone treatment of prostate cancer. Part I: the androgen receptor and steroidogenic pathways.
    Pitts WR
    BJU Int; 2009 Nov; 104(9):1304. PubMed ID: 19824968
    [No Abstract]   [Full Text] [Related]  

  • 19. RTOG clinical trials for prostate cancer.
    DeMare PA
    Hawaii Med J; 2007 Oct; 66(10):273-4, 276. PubMed ID: 18065125
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis and treatment of primary signet-ring cell carcinoma of the prostate.
    Lilleby W; Axcrona K; Alfsen GC; Urnes T; Hole KH
    Acta Oncol; 2007; 46(8):1195-7. PubMed ID: 17851841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.